Pancreatic Cancer Research

ResearcherNorthern Jiangsu People's HospitalNo recent work listed

Feiyu Mao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3170-0440; OpenAlex author ID A5062120072. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 3 papers · 2021: 3 papers · 2022: none · 2023: 1 paper

Papers 7

  1. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer. Co-author DOI 10.1007/s00432-023-05015-3↗
  2. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling. Co-author DOI 10.1007/s00432-020-03447-9↗
  3. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.1155/2021/6656337↗
  4. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma. Co-author DOI 10.18632/aging.202377↗
  5. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling. Co-author DOI 10.1002/jcp.29685↗
  6. High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma. Co-author DOI 10.1155/2020/8868245↗
  7. Distal pancreatectomy with en bloc celiac axis resection does not improve the R0 rate or median survival time of patients with locally advanced pancreatic canc… Co-author DOI 10.21037/tcr-19-2421↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zechang Xin · 6 shared papers, 2020–2021 · strength 0.79
  2. Yan Du · 5 shared papers, 2020–2021 · strength 0.66
  3. Peng Xu · 5 shared papers, 2020–2021 · strength 0.66
  4. Jie J. Yao · 5 shared papers, 2020–2021 · strength 0.66
  5. Jianjun Qian · 3 shared papers, 2020–2021 · strength 0.36
  6. Zhennan Li · 3 shared papers, 2020–2021 · strength 0.36
  7. Qingbo Feng · 2 shared papers, 2020–2021 · strength 0.27
  8. Duguang Li · 2 shared papers, 2020 · strength 0.23
  9. Anlai Ji · 1 shared paper, 2023 · strength 0.22
  10. Qiang Zhang · 1 shared paper, 2023 · strength 0.22
  11. Da Li · 1 shared paper, 2023 · strength 0.22
  12. Jie J. Yao · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.